Literature DB >> 21416635

Interobserver variability amongst cytopathologists and histopathologists in the diagnosis of neoplastic follicular patterned lesions of thyroid.

Rajan Duggal1, Arvind Rajwanshi, Nalini Gupta, Rakesh Kumar Vasishta.   

Abstract

The difficulty in correctly identifying follicular lesions/neoplasms (FN) of thyroid is a well recognized fact. The present study was undertaken to study the degree of interobserver variability among cytopathologists and histopathologists in the diagnosis of these lesions. A total of 74 cases were chosen with a cytological diagnosis varying from FN (43 cases), hürthle cell neoplasm (18 cases), neoplasm suspicious of papillary carcinoma (7 cases) and follicular variant of papillary carcinoma (FVPTC) (4 cases) and neoplasm, NOS (2 cases). All these cases were reviewed by a cytopathologist along with surgical follow-up. In cases of cytohistological discordance, histopathological diagnoses were also reviewed by a histopathologist. The accuracy of initial and reviewed cytology in predicting neoplastic histological outcome was 100%; however 15 cases were over-diagnosed on initial cytology as FN and on reviewed cytology, 8/15 cases were under-diagnosed as non-neoplastic; however still seven cases were over-diagnosed on reviewed cytology, thereby specificity for neoplastic histological outcome ranging from 50 to 68%. The histopathology diagnosis was reviewed and changed in six cases; therefore interobserver agreement among histopathologist is 92% which reduces further in diagnosis of FVPTC, as in two cases diagnosis of follicular adenoma was changed to FVPTC. Neoplastic follicular patterned lesions (FN) pose diagnostic difficulties among pathologists. So, all cases with a cytological diagnosis of FN should be reviewed along with histopathology to minimize interobserver variability and reviewed histopathology should be considered as "gold standard".
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21416635     DOI: 10.1002/dc.21363

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  8 in total

1.  The cancer genome atlas research network: a sight to behold.

Authors:  Thomas J Giordano
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

2.  Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics.

Authors:  Lamya Rezig; Adele Servadio; Liborio Torregrossa; Paolo Miccoli; Fulvio Basolo; Laetitia Shintu; Stefano Caldarelli
Journal:  Metabolomics       Date:  2018-10-10       Impact factor: 4.290

3.  The Clinical and Pathological Presentation of Thyroid Nodules in Children and the Comparison with Adult Population: Experience of a Single Institution.

Authors:  Tamas Solymosi; Gyula Lukacs Toth; Laszlo Budai; Istvan Gal
Journal:  Int J Endocrinol       Date:  2016-03-20       Impact factor: 3.257

4.  Role of phospho-ezrin in differentiating thyroid carcinoma.

Authors:  Lakshmi Mohan Lathika; Jagathnath Krishna Kumarapillai Mohanan Nair; Valliamma Neelakandapilla Saritha; Kunjuraman Sujathan; Sreeharshan Sreeja
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

5.  Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.

Authors:  Martin Hysek; Johan O Paulsson; Kenbugul Jatta; Ivan Shabo; Adam Stenman; Anders Höög; Catharina Larsson; Jan Zedenius; Carl Christofer Juhlin
Journal:  Cancers (Basel)       Date:  2019-09-26       Impact factor: 6.639

6.  DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.

Authors:  Hui Zhang; Zhenzhen Zhang; Xiaoding Liu; Huanli Duan; Tianmin Xiang; Qiye He; Zhixi Su; Huanwen Wu; Zhiyong Liang
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

7.  Better understanding in the differentiation of thyroid follicular adenoma, follicular carcinoma, and follicular variant of papillary carcinoma: a retrospective study.

Authors:  Jung Hyun Yoon; Eun-Kyung Kim; Ji Hyun Youk; Hee Jung Moon; Jin Young Kwak
Journal:  Int J Endocrinol       Date:  2014-09-18       Impact factor: 3.257

8.  Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants.

Authors:  Tomasz Stokowy; Danuta Gawel; Bartosz Wojtas
Journal:  Int J Endocrinol       Date:  2016-08-30       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.